Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Infrared light therapy may potentially benefit people with dementia

Infrared light therapy might have the potential to help people living with dementia, according to researchers.

19 Oct 2021

Research may provide clues to how viral infections contribute to neurodegeneration

Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the scientific journal "Nature Communications".

19 Oct 2021

Research reveals new role of immune cells that protect the brain from disease and injury

University of Virginia School of Medicine researchers have revealed a vital but previously unknown role for immune cells that protect the brain from disease and injury: The cells, known as microglia, also help regulate blood flow and maintain the brain's critical blood vessels.

18 Oct 2021

Mapping proteo-genomic connections between different human diseases

Hundreds of connections between different human diseases have been uncovered through their shared origin in our genome by an international research team led by scientists from the Medical Research Council Epidemiology Unit at the University of Cambridge, challenging the categorization of diseases by organ, symptoms, or clinical specialty.

15 Oct 2021

Experts review progress in using photobiomodulation therapy to treat diverse brain disorders

Photobiomodulation (PBM) offers exciting opportunities for improving the life of patients with a diverse range of brain disorders.

14 Oct 2021

Study reveals underrepresentation of women in stroke clinical trials

A new study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population.

13 Oct 2021

EQIPD consortium develops quality system to facilitate adherence to evidence-based research practices

The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the EQIPD Innovative Medicines Initiative (IMI) project.

12 Oct 2021

Personality traits associated with hallmarks of Alzheimer’s disease

New research from the Florida State University College of Medicine found that changes in the brain associated with Alzheimer's disease are often visible early on in individuals with personality traits associated with the condition.

12 Oct 2021

Oxidation-antioxidant imbalance in the blood may be an early indicator of Alzheimer's disease

Research conducted by the Ph.D student Mohamed Raâfet Ben Khedher and the postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer's disease, rather than a consequence.

12 Oct 2021

Common oral diuretic pill may be a potential candidate for Alzheimer's treatment

A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration may be a potential candidate for an Alzheimer's disease treatment for those who are at genetic risk, according to findings published in Nature Aging.

11 Oct 2021

Study investigates the link between gray matter and white matter neurodegeneration in subjective cognitive decline

Aging-US published "The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline" which reported that subjective cognitive complaints were assessed through 9 questions covering amnestic and non-amnestic cognitive domains. In these authors' cohorts, 123 individuals endorsed from one to six subjective cognitive complaints, while 102 individuals reported zero complaints.

11 Oct 2021

Researchers discover molecules in the blood that can indicate impending dementia

Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the blood that can indicate impending dementia. Their findings, which are presented in the scientific journal "EMBO Molecular Medicine", are based on human studies and laboratory experiments. Various university hospitals across Germany were also involved in the investigations.

11 Oct 2021

Genetics can influence a person's response to Alzheimer's disease pathology, research suggests

A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer's disease pathology.

8 Oct 2021

High fat diet exacerbates Alzheimer's disease in mouse model

Research has shown that individuals who have diabetes are more prone to develop dementia. Although people are widely aware of diabetes, owing to its common occurrence, they are less aware of prediabetes. Similar to diabetes, prediabetes is also associated with impaired glucose tolerance. However, unlike diabetes, patients with prediabetes show a slight increase in insulin and fasting blood glucose rather than hyperglycemia.

7 Oct 2021

Existing drug reduces obesity and fatty liver in mice without changes in food intake or daily activity

Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer's disease, schizophrenia and sickle cell disease reduces obesity and fatty liver in mice and improves their heart function — without changes in food intake or daily activity.

7 Oct 2021

New technology shows great promise for early diagnosis of Alzheimer’s disease

A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer's disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States.

7 Oct 2021

Toxic fatty acids trigger cell death in damaged neurons

Cells that normally nourish healthy brain cells called neurons release toxic fatty acids after neurons are damaged, a new study in rodents shows.

6 Oct 2021

Detailed atlas of the mammalian primary motor cortex will provide a springboard for future research

The NIH Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative Cell Census Network (BICCN) has unveiled an atlas of cell types and an anatomical neuronal wiring diagram for the mammalian primary motor cortex, derived from detailed studies of mice, monkeys, and humans.

6 Oct 2021

New digital game could help people over 50s to fight against Alzheimer's disease and dementia

UQ Healthy Living is helping over 50s in the fight against Alzheimer's disease and dementia, with a new digital game designed to train both the body and the brain.

6 Oct 2021

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain.

6 Oct 2021

Alzheimer's Disease News and Research

Further Reading

Infrared light therapy may potentially benefit people with dementia

Research may provide clues to how viral infections contribute to neurodegeneration

Research reveals new role of immune cells that protect the brain from disease and injury

Mapping proteo-genomic connections between different human diseases

Experts review progress in using photobiomodulation therapy to treat diverse brain disorders

Study reveals underrepresentation of women in stroke clinical trials

EQIPD consortium develops quality system to facilitate adherence to evidence-based research practices

Personality traits associated with hallmarks of Alzheimer’s disease

Oxidation-antioxidant imbalance in the blood may be an early indicator of Alzheimer's disease

Common oral diuretic pill may be a potential candidate for Alzheimer's treatment

Study investigates the link between gray matter and white matter neurodegeneration in subjective cognitive decline

Researchers discover molecules in the blood that can indicate impending dementia

Genetics can influence a person's response to Alzheimer's disease pathology, research suggests

High fat diet exacerbates Alzheimer's disease in mouse model

Existing drug reduces obesity and fatty liver in mice without changes in food intake or daily activity

New technology shows great promise for early diagnosis of Alzheimer’s disease

Toxic fatty acids trigger cell death in damaged neurons

Detailed atlas of the mammalian primary motor cortex will provide a springboard for future research

New digital game could help people over 50s to fight against Alzheimer's disease and dementia

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News